Skip to main content

Table 1 Control, Parkinson’s disease non-dementia (PDND), Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) cases: demographic and clinical data

From: Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease

 

Control (n = 17)

PDND (n = 23)

PDD (n = 12)

DLB (n = 10)

Mean age at onset (years) ± SD

N/A

61.1 ± 9.1

58.2 ± 7.7

69.7 ± 7.3

Mean age at death (years) ± SD

79.2 ± 8.7

77.7 ± 6.2

77.85 ± 6.1

77.0 ± 9.0

Mean disease duration (years) ± SD

N/A

16.6 ± 6.7

19.7 ± 6.5

7.3 ± 2.0

Gender (%)

3 (18) female

13 (57) female

6 (50) female

4 (40) female

Mean post-mortem delay (hours) ± SD

37.0 ± 16.6

63.6 ± 27.0

38.2 ± 21.7

28.0 ± 10.9

Mean time to dementia (years) ± SD

N/A

N/A

14.6 ± 6.9

N/A

Median Braak tangle stage (range)

II (0 to III)

II (I to IV)

II (I to IV)

II (0 to III)

  1. N/A, not available; n, number; SD, standard deviation.